Khosla Ventures

Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. It provides capital and strategic guidance to startups across stages, focusing on technology-driven companies in areas such as artificial intelligence, climate and sustainability, enterprise software and services, fintech, digital health, medical technology and diagnostics, therapeutics, consumer products, and frontier technologies. The firm backs bold ventures with the potential to disrupt markets and improve lives, supporting companies from early to growth stages and working closely with entrepreneurs to apply science, technology and innovative business models. While primarily investing in North American technology companies, Khosla Ventures pursues opportunities globally and emphasizes experimentation and impact alongside financial returns. The firm also maintains related impact initiatives that support entrepreneurs addressing socio-economic challenges in emerging markets.

Alex Bentley

Partner and Investor

Nessan Bermingham Ph.D

Operating Partner

Ryno Blignaut

Operating Partner

Alice Brooks

Partner

Peter Buckland JD

General Partner and COO

Past deals in Technology

Overture Life

Venture Round in 2025
Overture Life, Inc. is a biotechnology company based in New York, established in 2017, that specializes in developing robotic solutions for in vitro fertilization (IVF) applications. The company focuses on automating the IVF process through innovative medical devices and embryo testing methodologies, which enhance the efficiency and success rates of fertility treatments. By optimizing resource use and lowering costs, Overture Life aims to make IVF more accessible to a broader audience. Its technology includes automated cryopreservation and embryo testing services, enabling fertility clinics to identify viable embryos prior to implantation, thereby improving patient outcomes and supporting individuals in their journey to parenthood.

Science

Convertible Note in 2025
Science is a startup company that develops technologies for a range of serious unmet medical needs.

Mainspring

Series F in 2025
Mainspring Energy, Inc. is a technology company based in Menlo Park, California, that specializes in developing linear generator technology for low carbon, dispatchable energy solutions. Founded in 2010 by three Stanford engineers, the company focuses on creating advanced prototypes that convert fuel into electricity through a unique, low-temperature reaction of air and fuel. This innovative approach allows Mainspring to offer generators that provide affordable, reliable electricity while significantly reducing carbon emissions compared to traditional electric grids. The company's mission is to address climate change and enhance energy accessibility, contributing to the development of net-zero carbon energy systems for the future.

Hook

Seed Round in 2025
Hook operates as a music expression platform that harnesses the power of AI.

Nomagic

Series B in 2025
Nomagic, Inc. is a technology company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce. The company develops smart pick-and-place robotic systems that enhance efficiency, flexibility, and reliability in warehouses. By automating tedious tasks, Nomagic's solutions help reduce fulfillment costs and address labor shortages, allowing operations to scale effectively and operate around the clock. Powered by artificial intelligence, their robotic systems continuously learn and adapt to changing conditions, enabling warehouse operators to improve agility and ensure reliable delivery of goods. Nomagic's technology has been implemented in notable locations, including packing lines at Cdiscount, a leading French eCommerce platform.

Atomicwork

Series A in 2025
Founded in 2022, Atomicwork is a San Francisco-based company specializing in modern service management software. Its platform integrates with popular tools like Microsoft Teams and Slack, enabling employees to resolve IT issues directly from these platforms without needing to access separate portals.

Mooncake Labs

Seed Round in 2024
Mooncake Labs is building the modern lakehouse for every developer and application. We are an open source studio based in SF.

OpenAI

Venture Round in 2024
OpenAI is an AI research and deployment company that develops general-purpose artificial intelligence technologies and applies them to real-world problems. It conducts machine learning research and builds systems such as large-scale language models, multimodal input handling, and code generation to support automation, data analysis, content generation, and interactive problem solving across industries including technology, healthcare, and education. The organization offers platforms and APIs that enable enterprises, developers, and researchers to build, test, and deploy intelligent systems, with plug-in extensibility and ongoing model updates to improve performance and safety.

Enzymit

Series A in 2024
Enzymit is a biotechnology company focused on revolutionizing global manufacturing through sustainable and efficient bio-production methods. It specializes in developing cell-free bio-production technology that aims to eliminate the inefficiencies and complexities associated with traditional bio-production. Enzymit employs artificial intelligence and deep learning algorithms to design novel enzymes, which serve as molecular machines capable of transforming abundant feedstocks into valuable products, including pharmaceuticals, cosmetics, food, and materials. The company’s small, modular bio-reactors facilitate this process, promoting resource independence while minimizing environmental impact. By moving away from conventional whole-cell methods to utilizing nature's elemental building blocks, Enzymit enhances cost-effectiveness, efficiency, and sustainability in bio-production, while also providing greater flexibility in product customization for various industries.

Distyl AI

Series A in 2024
Distyl AI collaborates with organizations worldwide to enhance their artificial intelligence readiness. It develops integrated AI-based solutions tailored to clients' unique data, workflows, and employee requirements, enabling seamless integration with existing technologies.

Synex Medical

Series A in 2024
Synex Medical is a company focused on advancing health monitoring technology through non-invasive blood testing. It has developed a portable device that utilizes a miniaturized magnetic resonance system to measure blood metabolites without the need for skin penetration. This innovative approach employs only magnets and radio waves, ensuring no adverse health effects for users. By accurately measuring critical metabolites such as glucose, lactate, and ketones, Synex Medical's technology empowers individuals to monitor their health proactively and make informed decisions about their well-being.

Openwater

Venture Round in 2024
Openwater is a medical technology startup founded in 2016 and based in San Francisco, California. The company specializes in developing advanced wearable devices that utilize novel optoelectronics to achieve MRI-like resolution for medical diagnostics and treatments. By employing LCDs with small pixels, Openwater's technology creates holographic images that reduce scattering, enabling physicians to visualize the inner workings of the body and brain at a cellular level. This innovation allows for precise diagnosis and targeted treatment of diseases by manipulating or destroying individual cells without damaging surrounding tissue. Openwater aims to revolutionize medical imaging and improve patient outcomes through its cutting-edge approach.

Fortera

Series C in 2024
Fortera is a company focused on developing innovative solutions for the cement and concrete industry with the aim of significantly reducing carbon dioxide emissions. It has created a process that captures industrial carbon dioxide emissions and mineralizes them to produce a more environmentally friendly form of concrete. This method not only addresses the substantial carbon footprint associated with traditional concrete production but also offers improved performance characteristics. By providing sustainable alternatives to conventional cement products, Fortera contributes to global efforts to mitigate climate change and enhance the environmental sustainability of construction practices.

Q Bio

Venture Round in 2024
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Planted Solar

Series A in 2024
Planted Solar develops and deploys solar power plants using a rapid deployment platform that increases energy output per acre and accelerates project delivery. It combines development software, terrain-adaptive high-density racking, and automated construction to build flexible, all-terrain power plants. Through advanced site planning and logistics, the company aims to maximize land use and streamline solar development, enabling faster, scalable deployment of clean energy.

Cartwheel

Seed Round in 2024
Cartwheel is a technology company that specializes in a text-to-animation platform. Users can input text to generate animations for various applications, such as videos, games, and social media, without requiring prior animation experience. The platform leverages artificial intelligence to facilitate creative storytelling more efficiently.

Glydways

Series B in 2024
Glydways is a South San Francisco-based company specializing in affordable autonomous transportation systems. It designs, manufactures, installs, and operates efficient, high-capacity mobility solutions that are environmentally friendly with zero greenhouse gas emissions.

Li Industries

Series B in 2024
Li Industries is a start-up focused on advancing lithium-ion battery recycling technologies. The company specializes in the recovery of valuable materials such as lithium, cobalt, and nickel from end-of-life batteries used in electric vehicles, consumer electronics, and other energy storage systems. By utilizing innovative direct recycling technology and a scalable electrochemical flow system, Li Industries aims to extract these essential metals efficiently and sustainably. This process not only reduces environmental waste but also supports the production of new batteries from recycled components. By optimizing the recovery and treatment of these materials, Li Industries contributes to lowering energy consumption and emissions in the battery production process, ultimately fostering a more sustainable supply chain for battery manufacturing.

Pascal

Seed Round in 2024
Pascal is a technology company developing solid refrigerants to replace traditional gaseous ones in HVAC systems. These refrigerants operate within similar temperature and pressure ranges but eliminate global warming potential, enabling businesses to enhance energy efficiency and reduce system size.

Yoneda Labs

Seed Round in 2024
Yoneda Labs is a developer of AI-based software designed to assist chemists in optimizing reaction parameters essential for the synthesis of drugs and materials. The platform enables users to determine critical factors such as temperature, concentration, and catalyst, thereby enhancing the efficiency and speed of chemical laboratory processes. By leveraging advanced artificial intelligence, Yoneda Labs aims to streamline the development of chemical reactions, ultimately facilitating faster innovation in the pharmaceutical and material sciences industries.

Rubedo Life Sciences

Series A in 2024
Rubedo Life Sciences, Inc. is a biopharmaceutical company based in Sunnyvale, California, focused on developing innovative therapies that target senescent cells implicated in age-related diseases. Established in 2018, the company utilizes its proprietary ALEMBIC drug discovery platform to create a pipeline of therapeutic candidates. These candidates are designed to selectively address senescent cells, as well as pro-inflammatory and pro-fibrotic cell populations that contribute to various chronic conditions, including pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. Rubedo's leadership team comprises industry experts with significant experience in drug development and commercialization across both large pharmaceutical companies and biotech firms.

Loft Labs

Series A in 2024
Loft Labs is a software company that enables organizations to scale self-service access to Kubernetes, from small teams to thousands of engineers. The company maintains several open-source projects, including DevSpace, vcluster, jsPolicy and kiosk, and provides a commercial platform called Loft that unifies these projects into a single Kubernetes platform. This platform gives engineers secure but unobstructed access to cloud resources, supports cloud-native engineering practices, and helps teams collaborate in shared clusters by managing access, namespaces, and user permissions.

Skyflow

Series B in 2024
Skyflow, Inc. specializes in providing a privacy-focused application program interface solution that enables businesses to securely store and manage sensitive user information, including personally identifiable information (PII), payment card information (PCI), and protected health information (PHI). Founded in 2017 and based in Los Altos, California, Skyflow offers a cloud-native data privacy vault that employs advanced encryption and tokenization techniques to protect sensitive data across various applications. Its platform simplifies compliance with stringent regulations such as HIPAA, GDPR, and CCPA, ensuring that businesses can effectively govern and utilize their data while maintaining privacy standards. Formerly known as Prekari Labs, Inc., the company rebranded to Skyflow in December 2019.

Koloma

Series B in 2024
Koloma is a company specializing in geologic hydrogen production. It leverages proprietary technology, data, and expertise to identify and develop geologic hydrogen resources. The company's data-driven approach aims to reduce global carbon emissions, enabling businesses to lower their environmental impact.

Moonwalk Biosciences

Series A in 2024
Moonwalk Biosciences is a genomic medicine startup focused on developing precision epigenetic therapeutics. The company specializes in creating a profiling and engineering technology platform that leverages advanced artificial intelligence predictions to offer a comprehensive view of the epigenome in both health and disease states. This innovative approach aims to revolutionize therapy discovery and development, enabling healthcare providers to reprogram cells back to their healthy state.

rabbit

Series A in 2023
rabbit inc. is a technology company developing consumer electronics driven by novel, simple, and intuitive interactive paradigms. rabbit is the creator of the Large Action Model (LAM), a new type of foundation model for human actions on computer applications, and rabbit OS, a personalized operating system through a natural language interface. rabbit's first product, rabbit r1, is an affordable companion device designed in collaboration with Teenage Engineering.

Encellin

Series A in 2023
Encellin Inc., established in 2016, is a biotechnology company based in San Francisco, California. It specializes in developing innovative thin-film cell encapsulation devices for cell-based therapeutics, aiming to improve the lives of patients with chronic diseases initially focusing on Type 1 diabetes. The company's technology enables encapsulated cells to function as smart molecular factories, providing potential therapeutic solutions.

Sarvam AI

Series A in 2023
Sarvam AI specializes in developing an artificial intelligence platform tailored to India's diverse linguistic landscape. The platform aims to enhance the robustness, performance, and cost-effectiveness of generative AI app development, deployment, and distribution.

Forward

Series E in 2023
Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

Tabnine

Series B in 2023
Tabnine, Inc. is an artificial intelligence company based in Toronto, Canada, founded in 2018. It specializes in an AI-powered autocompletion software designed to enhance the efficiency of code writing for developers. The platform analyzes code snippets and learns from existing code patterns to provide reliable code predictions, helping development teams streamline the software development process without compromising privacy and security. Tabnine’s technology autocompletes lines of code within integrated development environments (IDEs) and includes an AI chat agent that facilitates code explanations and automatically generates code, tests, and documentation from plain language prompts. This functionality allows clients to code more seamlessly while reducing the likelihood of errors. Tabnine operates as a subsidiary of Codota Dot Com Ltd.

Black Ore

Seed Round in 2023
Black Ore Technologies, established in 2022 and headquartered in Texas, USA, specializes in AI-driven financial services. The company's core product, Tax Autopilot, is an end-to-end automation solution for 1040 tax preparation, designed to streamline the process for Certified Public Accountants (CPAs) and tax firms. By leveraging artificial intelligence, Black Ore enables professionals to focus on client advisory services and practice growth.

Coframe

Seed Round in 2023
Coframe is a technology company that specializes in AI-driven A/B testing and personalization for websites and applications. Its platform continuously analyzes user interactions to optimize content, improving user experience, engagement, and conversion rates. Coframe's unique approach involves training multimodal models to understand user behavior and business goals, enabling user interfaces to autonomously enhance themselves over time.

Glydways

Series B in 2023
Glydways is a South San Francisco-based company specializing in affordable autonomous transportation systems. It designs, manufactures, installs, and operates efficient, high-capacity mobility solutions that are environmentally friendly with zero greenhouse gas emissions.

Quoherent

Seed Round in 2023
Quoherent is a technology company specializing in the development of portable quantum computer processors. It leverages topological insulators to create qubits, the fundamental units of quantum computing, offering inherent quantum state protection and operational versatility across diverse temperature ranges. By minimizing error correction requirements, Quoherent aims to advance the computational capabilities of the quantum computing industry.

rabbit

Seed Round in 2023
rabbit inc. is a technology company developing consumer electronics driven by novel, simple, and intuitive interactive paradigms. rabbit is the creator of the Large Action Model (LAM), a new type of foundation model for human actions on computer applications, and rabbit OS, a personalized operating system through a natural language interface. rabbit's first product, rabbit r1, is an affordable companion device designed in collaboration with Teenage Engineering.

CellFE

Series A in 2023
CellFE Inc. is a biotechnology company based in San Carlos, California, established in 2017. It specializes in the development of a microfluidics-based device designed to deliver gene-editing molecules into human cells. This innovative platform enhances the manufacturing and development of cell therapies by utilizing rapid cell compression techniques that facilitate the uptake of therapeutic molecules from surrounding fluids. By enabling the transport of hard-to-deliver molecules, CellFE aims to improve the effectiveness of treatments for various disorders, supporting medical researchers in their efforts to advance patient care and outcomes.

Alias Technologies

Seed Round in 2023
Alias Technologies seeks to expedite innovation by increasing the value of technological footprint. It assists enterprises in realizing their technology investment through vendor consolidation analyses, cost-cutting approaches, and industry experience.

Caelux

Series A in 2023
Caelux is a renewable energy company based in Pasadena, California, founded in 2014. It specializes in developing and manufacturing perovskite-on-glass technology for the terrestrial solar and commercial space industries. This innovative technology is designed to enhance solar device efficiency while minimizing the amount of semiconducting material required, thereby reducing production costs. Caelux's products improve power production and integrate seamlessly into existing photovoltaic module manufacturing processes, allowing users to lower installed costs and boost overall performance.

SiPhox Health

Seed Round in 2023
SiPhox Health, based in Cambridge, Massachusetts, specializes in designing and manufacturing innovative diagnostic solutions. The company develops next-generation diagnostics infrastructure, including at-home test kits and central lab systems. Their flagship product is a disposable biosensor cartridge that assesses 17 blood biomarkers, providing insights into inflammation, hormonal health, metabolic fitness, and cardiovascular health. SiPhox Health's platform merges biochemistry, photonic chip technology, integrated photonics, electronics, and microfluidics to enable sensitive readouts of immunoassays and nucleic acid tests, facilitating point-of-need and at-home diagnostics.

SiPhox Health

Series A in 2023
SiPhox Health, based in Cambridge, Massachusetts, specializes in designing and manufacturing innovative diagnostic solutions. The company develops next-generation diagnostics infrastructure, including at-home test kits and central lab systems. Their flagship product is a disposable biosensor cartridge that assesses 17 blood biomarkers, providing insights into inflammation, hormonal health, metabolic fitness, and cardiovascular health. SiPhox Health's platform merges biochemistry, photonic chip technology, integrated photonics, electronics, and microfluidics to enable sensitive readouts of immunoassays and nucleic acid tests, facilitating point-of-need and at-home diagnostics.

TeraWatt Technology

Series C in 2023
Founded in 2017, TeraWatt Technology designs and manufactures lithium-ion rechargeable batteries for various electrified applications. The company is headquartered in Santa Clara, California with a subsidiary in Tokyo, Japan.

Advocate

Seed Round in 2023
Advocate is a technology company that specializes in developing artificial intelligence applications to enhance interactions between government agencies and civilians. Its platform is designed to automate filing and response processes, thereby streamlining human processing, decision-making, and risk assessment for federal government benefits programs. By focusing on improving efficiency and effectiveness, Advocate aims to facilitate a more transparent and accessible application process for disabled Americans seeking government benefits. The company's services are intended to create a hassle-free experience for qualified claimants, ensuring that financial support is readily available to those who need it.

Korbit Technologies

Series A in 2023
Korbit Technologies, founded in 2018 and headquartered in Montreal, Canada, specializes in developing Korbi, an artificial intelligence tutor designed to enhance the learning experience for students globally. The AI-driven platform offers interactive exercises and conversations that adapt to individual learning profiles, delivering personalized pedagogical support such as definitions, explanations, examples, and visual aids. Korbi's features include hands-on exercises, quizzes, visual diagrams, and performance tracking, all aimed at improving learning outcomes and motivation. The company serves a diverse audience, including students, teachers, publishers, and corporations, and has successfully trained nearly 20,000 learners in data science and AI. Korbit Technologies is committed to democratizing education by providing high-quality, personalized learning experiences at an accessible cost, and it has gained recognition as one of the top AI startups globally, receiving positive media coverage from prominent publications.

Kind Humanoid

Pre Seed Round in 2023
Kind Humanoid develops intelligent humanoid robots powered by AI and large language models. These robots assist humans in various tasks, helping businesses optimize operations and automate processes.

Gather Health

Series A in 2023
Gather Health is an international healthcare technology company dedicated to empowering chronic disease patients to enhance their health. The company develops mobile and cloud-based healthcare applications that utilize cutting-edge medical and behavioral research to motivate and educate patients. By connecting physicians, patients, their families, and communities, Gather Health aims to provide continuous and holistic care that leads to improved health outcomes. The rise in chronic diseases such as obesity, diabetes, and hypertension has created a pressing need for effective patient care solutions, especially given the shortage of healthcare providers. Gather Health's flagship product, the Gather Health Diabetes platform, is currently utilized by physicians and patients in various cities across Hong Kong and India, including Mumbai and Bangalore, demonstrating positive health outcomes for users. Headquartered in Hong Kong, with additional offices in Beijing, New York, and India, the company boasts a diverse team of clinicians, health experts, interaction designers, and engineers experienced in the global healthcare landscape.

Light Field Lab

Series B in 2023
Light Field Lab, Inc. is a technology company specializing in the development of holographic display systems that create immersive visuals by projecting three-dimensional holograms into physical space. Founded in 2017 and based in San Jose, California, the company leverages advanced light field technology to generate multiple viewing angles that mimic real-world perceptions, allowing objects to appear to float in space without the need for head-mounted displays. Light Field Lab's innovations enable new opportunities in both consumer and enterprise markets, facilitating the integration of existing content into their holographic formats through a universal application programming interface. The company's mission is to pioneer a holographic future, advancing how visual media is experienced across various applications.

Mainspring

Series E in 2022
Mainspring Energy, Inc. is a technology company based in Menlo Park, California, that specializes in developing linear generator technology for low carbon, dispatchable energy solutions. Founded in 2010 by three Stanford engineers, the company focuses on creating advanced prototypes that convert fuel into electricity through a unique, low-temperature reaction of air and fuel. This innovative approach allows Mainspring to offer generators that provide affordable, reliable electricity while significantly reducing carbon emissions compared to traditional electric grids. The company's mission is to address climate change and enhance energy accessibility, contributing to the development of net-zero carbon energy systems for the future.

Aisera

Series D in 2022
Aisera, Inc. is a technology company based in Palo Alto, California, that specializes in artificial intelligence solutions aimed at automating tasks and workflows for enterprises and consumers. Established in 2017, Aisera offers a range of products including AI Service Desk and AI Customer Service, which cater to various functions such as IT, human resources, sales, and operations. The company’s AI Experience platform combines generative AI capabilities with domain-specific large language models to create customizable solutions that enhance user interactions and improve productivity. Aisera's technology facilitates auto-resolution of service issues and streamlines business processes, resulting in significant cost savings and increased efficiency for organizations across multiple sectors, including healthcare, finance, and retail. Recognized for its innovation, Aisera continues to lead in service automation through its advanced AI-driven offerings.

Wolfia

Pre Seed Round in 2022
Wolfia is an AI-powered platform that helps enterprises accelerate security reviews and close deals faster by automating and standardizing responses to security questionnaires and expert-level customer queries. The platform generates instant, precise answers, maintains consistency across submissions, and supports delivery through Slack and a web app, enabling sales and security teams to operate without heavy reliance on subject-matter experts. Used by growing technology companies such as CircleCI, Solve Intelligence, and Leya, Wolfia streamlines the information flow between buyers, security teams, and vendors, helping shorten sales cycles and unblock deals.

Li Industries

Series A in 2022
Li Industries is a start-up focused on advancing lithium-ion battery recycling technologies. The company specializes in the recovery of valuable materials such as lithium, cobalt, and nickel from end-of-life batteries used in electric vehicles, consumer electronics, and other energy storage systems. By utilizing innovative direct recycling technology and a scalable electrochemical flow system, Li Industries aims to extract these essential metals efficiently and sustainably. This process not only reduces environmental waste but also supports the production of new batteries from recycled components. By optimizing the recovery and treatment of these materials, Li Industries contributes to lowering energy consumption and emissions in the battery production process, ultimately fostering a more sustainable supply chain for battery manufacturing.

Tabnine

Venture Round in 2022
Tabnine, Inc. is an artificial intelligence company based in Toronto, Canada, founded in 2018. It specializes in an AI-powered autocompletion software designed to enhance the efficiency of code writing for developers. The platform analyzes code snippets and learns from existing code patterns to provide reliable code predictions, helping development teams streamline the software development process without compromising privacy and security. Tabnine’s technology autocompletes lines of code within integrated development environments (IDEs) and includes an AI chat agent that facilitates code explanations and automatically generates code, tests, and documentation from plain language prompts. This functionality allows clients to code more seamlessly while reducing the likelihood of errors. Tabnine operates as a subsidiary of Codota Dot Com Ltd.

TeraWatt Technology

Series B in 2022
Founded in 2017, TeraWatt Technology designs and manufactures lithium-ion rechargeable batteries for various electrified applications. The company is headquartered in Santa Clara, California with a subsidiary in Tokyo, Japan.

Ultima Genomics

Venture Round in 2022
Ultima Genomics is a biotechnology company established in 2016 and headquartered in Newark, California. It specializes in genome-scale sequencing technology, focusing on providing analytical services to various enterprises. By employing an open substrate, Ultima Genomics creates a vast, low-cost reaction surface that facilitates billions of reads without relying on expensive flow cells or complex fluidic systems. The company utilizes specialized sequencing hardware combined with machine learning techniques to ensure reproducible and accurate results. This innovative approach enables clients to obtain genomic reports at scale, enhancing the speed and efficiency of sequencing while significantly reducing costs. Ultima Genomics aims to harness the potential of genomic information to drive advancements in biology and improve human health.

Mainspring

Series E in 2022
Mainspring Energy, Inc. is a technology company based in Menlo Park, California, that specializes in developing linear generator technology for low carbon, dispatchable energy solutions. Founded in 2010 by three Stanford engineers, the company focuses on creating advanced prototypes that convert fuel into electricity through a unique, low-temperature reaction of air and fuel. This innovative approach allows Mainspring to offer generators that provide affordable, reliable electricity while significantly reducing carbon emissions compared to traditional electric grids. The company's mission is to address climate change and enhance energy accessibility, contributing to the development of net-zero carbon energy systems for the future.

Nomagic

Series A in 2022
Nomagic, Inc. is a technology company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce. The company develops smart pick-and-place robotic systems that enhance efficiency, flexibility, and reliability in warehouses. By automating tedious tasks, Nomagic's solutions help reduce fulfillment costs and address labor shortages, allowing operations to scale effectively and operate around the clock. Powered by artificial intelligence, their robotic systems continuously learn and adapt to changing conditions, enabling warehouse operators to improve agility and ensure reliable delivery of goods. Nomagic's technology has been implemented in notable locations, including packing lines at Cdiscount, a leading French eCommerce platform.

Enso

Seed Round in 2022
Enso is a creative impact agency founded in 2012 and headquartered in Santa Monica, California. The company leverages strategic, creative, and community-building skills to create positive change for the planet and individuals. It focuses on developing innovative ideas that challenge the status quo and have the potential for widespread scalability by fostering collaboration among brands, organizations, and individuals around shared missions. Additionally, Enso offers tools that enable rapid software creation, allowing business leaders, analysts, data scientists, and developers to collaboratively design workflows and enhance communication. Through its multifaceted approach, Enso aims to drive forward-thinking solutions that contribute to a better future.

Tarana Wireless

Venture Round in 2022
Tarana Wireless, Inc. is a technology company that specializes in researching, developing, and commercializing non-line-of-sight (NLoS) wireless transport solutions. Its flagship product, AbsoluteAir 2, offers advanced wireless transport capabilities with features such as deterministic True NLOS performance, extensive coverage, multi-kilometer range, and high spectral efficiency. The company provides construction-grade installation services and a carrier-class management system that allows operators to configure, monitor, and manage their network nodes effectively. Tarana's solutions are designed to support various applications, including small-cell backhaul, wireless fiber extension, and fixed wireless broadband access. The company serves tier-1 telecommunications operators globally and is headquartered in Milpitas, California, with additional offices in Berkeley, California, and Pune, India. Tarana Wireless was established in 2009 and has made significant advancements in wireless technology, offering lower total cost of ownership and unmatched scalability for its clients.

&Ava

Series A in 2022
Ava is a company that specializes in live captioning technology, utilizing artificial intelligence to transcribe spoken language into text. Its innovative platform is designed to enhance accessibility for the 466 million individuals who are deaf or hard of hearing worldwide. By providing instant captions and color-coded text, Ava's application facilitates seamless communication in group conversations, allowing users to actively participate in discussions and stay informed about their surroundings. This approach not only empowers deaf and hard-of-hearing individuals but also fosters improved connections among all participants in various social settings.

Volta Labs

Series A in 2022
Volta Labs, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company specializes in engineering and developing innovative tools for biological automation, focusing on scalable automation solutions for genetic engineering. Its platform is designed to revolutionize genomics research by providing affordable genomic sample preparation and automation for complex biological workflows. By integrating expertise from engineering, surface chemistry, and molecular biology, Volta Labs aims to streamline sample processing and enhance the capabilities of biotech organizations in the next generation of genomic automation.

Emi Labs

Series A in 2022
Emi Labs is a technology company that develops AI-powered recruitment software to transform the hiring process for firms with high-volume openings. Its flagship AI recruitment assistant engages applicants in natural conversations to identify qualified candidates while automating screening, skills validation, interview scheduling and document collection, thereby shortening hiring cycles and boosting recruiter productivity. The platform aims to improve the candidate experience and enable scalable, personalized engagement. The company operates a remote-first model with office hubs in Buenos Aires, Mexico City, and San Francisco.

WorkWhile

Series A in 2022
Founded in 2017, WorkWhile is a technology platform that connects skilled hourly laborers with job shifts across industries such as warehousing, light industrial work, delivery services, hospitality, food production, and event management. The platform uses cognitive science and behavioral analysis to match workers' skills, schedules, and locations with suitable jobs. It offers benefits like next-day pay and sick leave credits for its workforce.

Academia.edu

Series D in 2022
Academia.edu is the largest and fastest-growing platform in the world for sharing academic research. Its mission is to accelerate and democratize academic research. Over 150 million academics have signed up to Academia.edu, adding 25 million papers. Over 100,000 people join Academia.edu each day. Academia.edu attracts over 52 million unique visitors a month. 40% of the world's faculty log in to Academia.edu every month. The company was founded in 2008 and is headquartered in San Francisco, California.

Robin Healthcare

Series B in 2021
Robin Healthcare, Inc. is a healthcare technology company founded in 2017 and headquartered in Berkeley, California, with an additional office in Austin, Texas. The company specializes in developing innovative solutions for the medical industry, including a smart assistant device, clinical documentation solutions, and services for order and medication entry, chart review, billing and coding, and referral management. Robin Healthcare provides comprehensive medical scribe services designed to alleviate administrative burdens on healthcare providers, thereby enhancing the doctor-patient experience. By integrating technology and trained medical scribes directly into electronic medical records, the company aims to streamline workflows and allow physicians to focus more on patient care.

Lessen

Series B in 2021
Lessen is a technology-driven company that provides comprehensive outsourced property services for real estate rental assets, primarily focusing on single-family and multifamily renovations, turnovers, and maintenance. The company's platform facilitates seamless connections between real estate owners and service providers, offering on-demand resources and predictable service costs. Through its proprietary technology suite, Lessen enhances project management by incorporating automation and real-time analytics, thereby modernizing traditional processes in the industry. The company employs professional field project managers who ensure quality service and leverage a network of vetted service professionals across more than 40 markets nationwide. Lessen's approach enables efficient job verification, timely maintenance, and consistent service delivery for property owners and service providers alike.

Mimica Automation

Series A in 2021
Mimica Automation Limited is a London-based company established in 2018 that specializes in developing software to automate repetitive tasks through machine learning. The company's primary product observes users over a period of 2-3 weeks, capturing their clicks and keystrokes to understand their workflow. This data is then processed using advanced algorithms to create a comprehensive automation map, streamlining the user's tasks. Mimica's technology aims to enhance productivity by simplifying the automation process, allowing businesses to focus on more strategic activities.

Lightship

Series C in 2021
Founded in 2018, Lightship aims to enhance health equity globally by transforming clinical trials. It combines digital health innovations, technology, remote care, and high-quality clinical research to make studies more accessible and offer choices, keeping patients at the core of its work.

Enso

Seed Round in 2021
Enso is a creative impact agency founded in 2012 and headquartered in Santa Monica, California. The company leverages strategic, creative, and community-building skills to create positive change for the planet and individuals. It focuses on developing innovative ideas that challenge the status quo and have the potential for widespread scalability by fostering collaboration among brands, organizations, and individuals around shared missions. Additionally, Enso offers tools that enable rapid software creation, allowing business leaders, analysts, data scientists, and developers to collaboratively design workflows and enhance communication. Through its multifaceted approach, Enso aims to drive forward-thinking solutions that contribute to a better future.

Vicarious Surgical

Post in 2021
Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company specializes in developing advanced technologies for minimally invasive surgical procedures, focusing on enhancing surgical efficiency, improving patient outcomes, and reducing healthcare costs. Its flagship product, the Vicarious Surgical Robotic System, integrates virtual reality software with human-like robotic capabilities, enabling surgeons to perform complex surgeries with greater precision and control. Designed for abdominal access through a single port, the system is compact and portable, facilitating easy integration into existing operating rooms. By minimizing invasiveness, Vicarious Surgical aims to accelerate patient recovery times and decrease post-operative discomfort, thereby transforming the landscape of surgical care.

House Rx

Seed Round in 2021
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.

Eight Sleep

Series C in 2021
Eight Sleep is a pioneering sleep technology company that manufactures smart mattresses designed to optimize rest and improve overall health. Founded in 2014, the company's products include temperature-regulating mattresses, sleep trackers, and other accessories aimed at creating personalized, comfortable sleep environments.

Known Medicine

Seed Round in 2021
Known Medicine Inc. is a biotechnology company based in Salt Lake City, Utah, founded in 2020. The company specializes in developing a custom organoid platform designed for tumor sensitivity testing through advanced bioengineering techniques. Known Medicine focuses on transforming the process of evaluating how tumors respond to cancer therapies by taking tumor samples and breaking them down into microtumors. These microtumors are treated in specialized micro-environments using various methods to ascertain the most effective treatment options. The company's platform integrates machine learning with omics data to identify predictive biomarkers that inform oncologists about cancer cell behavior and potential treatment pathways, ultimately aiming to enhance personalized cancer care.

AREVO

Venture Round in 2021
AREVO, based in Silicon Valley, California, is a technology company specializing in direct digital additive manufacturing of ultra-strong, lightweight composite parts for high-volume end-use applications. The company combines advanced materials, powerful design and build software, and free motion robotics to achieve true three-dimensional construction. This innovative approach allows AREVO to move beyond prototyping, facilitating the design and production of large, mass-manufactured parts and structures. By leveraging the unique properties of composite materials, AREVO provides designers and manufacturers with exceptional flexibility and strength, targeting sectors such as aerospace, defense, consumer electronics, transportation, and consumer goods. With its cutting-edge technology, AREVO is positioned to optimize additive manufacturing services for original equipment manufacturers worldwide.

Kiddom

Series C in 2021
Founded in 2013, Kiddom is a San Francisco-based company that designs and develops a visual collaborative platform for K-12 classrooms. This platform combines curriculum management, instruction, assessment, and communication tools into one solution, supporting teachers and students in various learning scenarios.

Encellin

Seed Round in 2021
Encellin Inc., established in 2016, is a biotechnology company based in San Francisco, California. It specializes in developing innovative thin-film cell encapsulation devices for cell-based therapeutics, aiming to improve the lives of patients with chronic diseases initially focusing on Type 1 diabetes. The company's technology enables encapsulated cells to function as smart molecular factories, providing potential therapeutic solutions.

Berkshire Grey

Post in 2021
Berkshire Grey, Inc. is a technology company specializing in the development of artificial intelligence-driven robotic and automated material handling systems. Founded in 2013 and based in Lexington, Massachusetts, the company focuses on automating tasks traditionally performed by humans in commercial settings, enhancing efficiency in fulfillment, supply chain, and logistics operations. Its offerings include a range of robotic solutions, such as autonomous picking and sorting systems, mobile robotic units, and dynamic parcel sortation technologies. Additionally, Berkshire Grey provides electromechanical solutions that incorporate vision systems and advanced scanning technologies. By leveraging AI, computer vision, and machine learning, the company's systems enable clients to achieve higher accuracy and throughput speeds while managing diverse product assortments. The majority of its revenue is generated from North America, positioning Berkshire Grey as a significant player in the automation landscape.

Fortera

Series B in 2021
Fortera is a company focused on developing innovative solutions for the cement and concrete industry with the aim of significantly reducing carbon dioxide emissions. It has created a process that captures industrial carbon dioxide emissions and mineralizes them to produce a more environmentally friendly form of concrete. This method not only addresses the substantial carbon footprint associated with traditional concrete production but also offers improved performance characteristics. By providing sustainable alternatives to conventional cement products, Fortera contributes to global efforts to mitigate climate change and enhance the environmental sustainability of construction practices.

Lessen

Series A in 2021
Lessen is a technology-driven company that provides comprehensive outsourced property services for real estate rental assets, primarily focusing on single-family and multifamily renovations, turnovers, and maintenance. The company's platform facilitates seamless connections between real estate owners and service providers, offering on-demand resources and predictable service costs. Through its proprietary technology suite, Lessen enhances project management by incorporating automation and real-time analytics, thereby modernizing traditional processes in the industry. The company employs professional field project managers who ensure quality service and leverage a network of vetted service professionals across more than 40 markets nationwide. Lessen's approach enables efficient job verification, timely maintenance, and consistent service delivery for property owners and service providers alike.

Ellipsis Health

Series A in 2021
Founded in 2013, Ellipsis Health is a technology company that uses artificial intelligence to improve behavioral health. It analyzes patient speech and clinical data to predict health outcomes and provide real-time assessments for conditions like depression.

Hello Heart

Series C in 2021
Hello Heart Inc., established in 2013 and headquartered in Redwood City, California, specializes in developing digital health solutions. Its flagship product is Hello Heart, a mobile application designed to empower individuals to manage their heart health effectively. The app enables users to track their blood pressure and weight, providing real-time personalized tips based on clinical guidelines. Employers can also utilize this platform to proactively manage employee health risks associated with high blood pressure, fostering behavior change and preventing serious health issues.

Overture Life

Series B in 2021
Overture Life, Inc. is a biotechnology company based in New York, established in 2017, that specializes in developing robotic solutions for in vitro fertilization (IVF) applications. The company focuses on automating the IVF process through innovative medical devices and embryo testing methodologies, which enhance the efficiency and success rates of fertility treatments. By optimizing resource use and lowering costs, Overture Life aims to make IVF more accessible to a broader audience. Its technology includes automated cryopreservation and embryo testing services, enabling fertility clinics to identify viable embryos prior to implantation, thereby improving patient outcomes and supporting individuals in their journey to parenthood.

Mainspring

Series D in 2021
Mainspring Energy, Inc. is a technology company based in Menlo Park, California, that specializes in developing linear generator technology for low carbon, dispatchable energy solutions. Founded in 2010 by three Stanford engineers, the company focuses on creating advanced prototypes that convert fuel into electricity through a unique, low-temperature reaction of air and fuel. This innovative approach allows Mainspring to offer generators that provide affordable, reliable electricity while significantly reducing carbon emissions compared to traditional electric grids. The company's mission is to address climate change and enhance energy accessibility, contributing to the development of net-zero carbon energy systems for the future.

Apton Biosystems

Series A in 2021
Apton Biosystems, Inc. is a biotechnology company based in Pleasanton, California, founded in 2012. The company specializes in developing advanced optical systems for sequencing and protein detection, utilizing super-resolution technology to analyze molecules that are spaced closer than the wavelength of light. This innovative approach facilitates multi-omic sequencing and single-molecule protein detection, significantly enhancing capabilities in biomarker discovery, early disease detection, and therapeutic monitoring. Apton Biosystems aims to advance preventive health and precision medicine by addressing spatial challenges in high-density sequencing and protein analysis, thus contributing to improved healthcare outcomes.

StimScience

Seed Round in 2021
StimScience develops non-invasive brain stimulation technologies, including transcranial direct current stimulation, transcranial alternating current stimulation, and transcranial random noise stimulation. Its NeuroMod tXES platform enables users to generate arbitrary waveforms for tailored tES applications. Founded in 2017 and based in Berkeley, California, StimScience focuses on commercializing neuroscience and sleep research into products and services for individuals, employers, and health plans. The team comprises leading sleep and neuroscience researchers and advisors, with early funding supporting the launch of Somnee, an advanced diagnostic and therapeutic product designed to help people fall asleep faster and achieve higher-quality restorative sleep. Sleep health is central to mental health, memory, learning, and physical well-being.

Forward

Series D in 2021
Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

vFunction

Seed Round in 2021
VFunction specializes in application modernization for businesses. Its core product facilitates the transformation of existing Java applications into cloud-native architectures, helping companies stay competitive through digital evolution. The company's team, with their unique expertise, empowers clients to modernize their core business applications efficiently.

Earli

Series A in 2021
Earli is a biotechnology company focused on advancing cancer detection and treatment through innovative technology. The company specializes in developing devices that utilize a novel gene therapy approach known as Synthetic Biopsy. This method compels cancer cells to produce synthetic biomarkers, which are not naturally occurring in the human body. These biomarkers can then be detected in bodily fluids such as blood, urine, or breath, allowing for early identification of cancer. By facilitating the early detection of homogeneous tumors, Earli aims to significantly improve the chances of successful treatment and personalize therapy options for patients. Additionally, the technology is designed to be visible during imaging procedures such as PET scans, enhancing the monitoring of cancer progression and treatment efficacy.

WorkWhile

Seed Round in 2020
Founded in 2017, WorkWhile is a technology platform that connects skilled hourly laborers with job shifts across industries such as warehousing, light industrial work, delivery services, hospitality, food production, and event management. The platform uses cognitive science and behavioral analysis to match workers' skills, schedules, and locations with suitable jobs. It offers benefits like next-day pay and sick leave credits for its workforce.

Uhnder

Series C in 2020
Uhnder Inc. is a technology company that specializes in developing innovative products for sensing, cognition, and communication within the Internet of Things (IoT) market. Founded in 2015 and headquartered in Austin, Texas, with additional engineering and operations in St. Louis, Uhnder is recognized for its digital automotive radar-on-chip. This technology serves as a more accurate and reliable alternative to traditional light detection and ranging (lidar) systems, enhancing the safety and responsiveness of autonomous vehicles. The chip is designed to prevent collisions, alert drivers to potential hazards, and facilitate quick localization for navigation. By offering this advanced solution, Uhnder aims to significantly improve the automation capabilities of manufacturers in the automotive sector.

Aisera

Series C in 2020
Aisera, Inc. is a technology company based in Palo Alto, California, that specializes in artificial intelligence solutions aimed at automating tasks and workflows for enterprises and consumers. Established in 2017, Aisera offers a range of products including AI Service Desk and AI Customer Service, which cater to various functions such as IT, human resources, sales, and operations. The company’s AI Experience platform combines generative AI capabilities with domain-specific large language models to create customizable solutions that enhance user interactions and improve productivity. Aisera's technology facilitates auto-resolution of service issues and streamlines business processes, resulting in significant cost savings and increased efficiency for organizations across multiple sectors, including healthcare, finance, and retail. Recognized for its innovation, Aisera continues to lead in service automation through its advanced AI-driven offerings.

&Ava

Seed Round in 2020
Ava is a company that specializes in live captioning technology, utilizing artificial intelligence to transcribe spoken language into text. Its innovative platform is designed to enhance accessibility for the 466 million individuals who are deaf or hard of hearing worldwide. By providing instant captions and color-coded text, Ava's application facilitates seamless communication in group conversations, allowing users to actively participate in discussions and stay informed about their surroundings. This approach not only empowers deaf and hard-of-hearing individuals but also fosters improved connections among all participants in various social settings.

Glydways

Venture Round in 2020
Glydways is a South San Francisco-based company specializing in affordable autonomous transportation systems. It designs, manufactures, installs, and operates efficient, high-capacity mobility solutions that are environmentally friendly with zero greenhouse gas emissions.

Rubedo Life Sciences

Seed Round in 2020
Rubedo Life Sciences, Inc. is a biopharmaceutical company based in Sunnyvale, California, focused on developing innovative therapies that target senescent cells implicated in age-related diseases. Established in 2018, the company utilizes its proprietary ALEMBIC drug discovery platform to create a pipeline of therapeutic candidates. These candidates are designed to selectively address senescent cells, as well as pro-inflammatory and pro-fibrotic cell populations that contribute to various chronic conditions, including pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. Rubedo's leadership team comprises industry experts with significant experience in drug development and commercialization across both large pharmaceutical companies and biotech firms.

WaveOne

Series A in 2020
WaveOne, Inc. is a technology company based in Palo Alto, California, that specializes in developing advanced video and image compression software. Founded in 2016, the company leverages machine learning and artificial intelligence to create custom-tailored, context-dependent solutions for digital media compression. WaveOne's technology utilizes a codec that operates significantly faster than traditional methods, enabling the processing of images at high speeds while maintaining clarity. This innovation allows digital media industries to efficiently process, print, upload, and share high-quality images, positioning WaveOne at the forefront of digital media technology.

Invoy

Series A in 2020
Invoy is a company focused on enhancing health and weight loss outcomes through the integration of science, data, and artificial intelligence. It develops a monitoring medical device that offers personalized nutrition and wellness services by generating real-time data on an individual's metabolism. This device not only provides tailored, predictive nutrition recommendations but also features affordable breath analyzers for medical applications. By addressing the unique body chemistry of each individual, Invoy aims to empower users to achieve their specific health and wellness objectives.

SiPhox Health

Seed Round in 2020
SiPhox Health, based in Cambridge, Massachusetts, specializes in designing and manufacturing innovative diagnostic solutions. The company develops next-generation diagnostics infrastructure, including at-home test kits and central lab systems. Their flagship product is a disposable biosensor cartridge that assesses 17 blood biomarkers, providing insights into inflammation, hormonal health, metabolic fitness, and cardiovascular health. SiPhox Health's platform merges biochemistry, photonic chip technology, integrated photonics, electronics, and microfluidics to enable sensitive readouts of immunoassays and nucleic acid tests, facilitating point-of-need and at-home diagnostics.

AREVO

Series B in 2020
AREVO, based in Silicon Valley, California, is a technology company specializing in direct digital additive manufacturing of ultra-strong, lightweight composite parts for high-volume end-use applications. The company combines advanced materials, powerful design and build software, and free motion robotics to achieve true three-dimensional construction. This innovative approach allows AREVO to move beyond prototyping, facilitating the design and production of large, mass-manufactured parts and structures. By leveraging the unique properties of composite materials, AREVO provides designers and manufacturers with exceptional flexibility and strength, targeting sectors such as aerospace, defense, consumer electronics, transportation, and consumer goods. With its cutting-edge technology, AREVO is positioned to optimize additive manufacturing services for original equipment manufacturers worldwide.

Vicarious Surgical

Series A in 2020
Vicarious Surgical Inc. is a robotics company based in Charlestown, Massachusetts, established in 2014. The company specializes in developing advanced technologies for minimally invasive surgical procedures, focusing on enhancing surgical efficiency, improving patient outcomes, and reducing healthcare costs. Its flagship product, the Vicarious Surgical Robotic System, integrates virtual reality software with human-like robotic capabilities, enabling surgeons to perform complex surgeries with greater precision and control. Designed for abdominal access through a single port, the system is compact and portable, facilitating easy integration into existing operating rooms. By minimizing invasiveness, Vicarious Surgical aims to accelerate patient recovery times and decrease post-operative discomfort, thereby transforming the landscape of surgical care.

Cover

Series A in 2020
Cover is a technology company that specializes in the design, manufacture, and installation of custom backyard studios and guesthouses. Its mission is to provide access to thoughtfully designed and well-built living spaces for a broader audience. By utilizing proprietary design software and a precision manufacturing system, Cover delivers high-quality, energy-efficient housing alternatives in significantly less time than traditional construction methods. The company focuses on enhancing living environments through an efficient process that includes design, permitting, manufacturing, and installation. Initially launched in Los Angeles, Cover is currently accepting pre-orders from customers around the world.

Kernel

Series C in 2020
Kernel, a neuroscience company founded in 2016 and headquartered in Los Angeles, California, develops advanced brain-recording technologies aimed at enhancing human cognition. The company specializes in creating a non-invasive brain interface that captures neural signals with quality comparable to traditional imaging methods like fMRI and MEG, while being as user-friendly as EEG. Kernel's primary focus is on addressing dysfunctions linked to neurodegenerative diseases, offering neuroprosthetics that can mimic, repair, and improve cognitive functions. Additionally, the company provides access to brain imaging devices that enable remote experimentation, thereby furthering the understanding and treatment of neurological disorders.

Menten AI

Seed Round in 2020
Menten AI, established in 2018 with headquarters in San Francisco and a satellite office in Toronto, is an early-stage biotech company specializing in drug discovery. It leverages machine learning and quantum computing to develop novel protein-based drugs and enzymes for pharmaceutical and chemical industries. Menten AI's core offering is a proprietary protein design algorithm tailored for current and near-term quantum computers, enabling efficient exploration of protein structures for therapeutic applications, such as oncology and neurodegeneration, and industrial enzyme development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.